pharma · Solid Tumors · RAS Mutation · KTTA
Pasithea Therapeutics
Pasithea Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Miami Beach, USA HQ
2020 Founded
11 Employees
Public company Type
KTTA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Miami Beach, USA
- Founded
- 2020
- Employees
- 11
- Programs
- 3
- Drugs
- 6
- Patents
- 0
Pasithea Therapeutics projects
3 ClinicalTrials.gov programs sponsored by Pasithea Therapeutics.
Pasithea Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Pasithea Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.